Drug intelligence / Profile preview

estradiol + levonorgestrel (Bayer)

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral
01

Overview

**Wellnara** is a continuous oral fixed-dose hormone replacement therapy containing estradiol 1 mg, supplied as estradiol hemihydrate, and levonorgestrel 0.04 mg per film-coated tablet. It is used to treat estrogen-deficiency symptoms in postmenopausal women; estradiol replaces declining endogenous estrogen activity, while the progestin levonorgestrel provides progestogenic opposition to estrogenic stimulation of the endometrium in women with a uterus. Bayer has also conducted post-marketing surveillance of Wellnara in Japan in postmenopausal osteoporosis. ([gelbe-liste.de](https://www.gelbe-liste.de/produkte/Wellnara-1-mg-0-04-mg-Filmtabletten_501079/fachinformation))

Brand names
Wellnara
Other names
E2/LNG oralestradiol + levonorgestrelestradiol hemihydrate + levonorgestrelestradiol/levonorgestrel
02

Targets

PR (Progesterone receptor)ESR2 (ERβ)GPER1 (G protein-coupled estrogen receptor 1)ESR1 (ERα)

Beyond the preview

Go deeper on estradiol + levonorgestrel (Bayer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on estradiol + levonorgestrel (Bayer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call